Differentiating Hypoglycemia from other diseases: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(4 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hypoglycemia}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Hypoglycemia]]
{{CMG}}; {{AE}} {{MAD}}
{{CMG}}; {{AE}} {{MAD}}


==Overview==
==Overview==
Hypoglycemia should be differentiated from other causes of [[autonomic]] hyperactivity symptoms. Physicians should have history, signs and laboratory results sufficient to help them to identify the cause of hypoglycemia. Neonatal hypoglycemia should be differentiated from other causes of neurological symptoms in neonates such as [[sepsis]], metabolic diseases: [[urea cycle disorders]], and branched-chain organic acidemias, [[hyponatremia]] and [[Asphyxia|neonatal asphyxia]].
Hypoglycemia should be differentiated from other causes of [[autonomic]] hyperactivity symptoms. Neonatal hypoglycemia should be differentiated from other causes of neurological symptoms in neonates such as [[sepsis]], metabolic diseases: [[urea cycle disorders]], and branched-chain organic acidemias, [[hyponatremia]] and [[Asphyxia|neonatal asphyxia]]. In adults, hypoglycemia should be differentiated from other diseases that may cause autonomic hyperactivity symptoms, such as [[hyperthyroidism]], [[anxiety]], [[Cardiac arrhythmia|arrhythmia]], and [[pheochromocytoma]].


==Differentiating Hypoglycemia from other Diseases==
==Differentiating Hypoglycemia from other Diseases==
Line 136: Line 136:
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<55
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<55
| style="background: #F5F5F5; padding: 5px;text-align: center;" |≥200
| style="background: #F5F5F5; padding: 5px;text-align: center;" |≥200
| style="background: #F5F5F5; padding: 5px;text-align: center;" |≥3
| style="background: #F5F5F5; padding: 5px;text-align: center;" |S.
| style="background: #F5F5F5; padding: 5px;text-align: center;" |≥5
| style="background: #F5F5F5; padding: 5px;text-align: center;" |≥5
| style="background: #F5F5F5; padding: 5px;text-align: center;" |≤2.7
| style="background: #F5F5F5; padding: 5px;text-align: center;" |≤2.7
Line 159: Line 159:
|}
|}


==== Differentiating Hypoglycemia from other Diseases that Cause autonomic hyperactivity symptoms ([[tachycardia]], [[hypertension]]): ====
==== Differentiating Hypoglycemia from other diseases that cause autonomic hyperactivity symptoms: ====
{| class="wikitable"
{| class="wikitable"
! rowspan="3" style="background: #4479BA; color: #FFFFFF; " |Disease
! rowspan="3" style="background: #4479BA; color: #FFFFFF; " |Disease
Line 165: Line 165:
! rowspan="3" style="background: #4479BA; color: #FFFFFF; " |Investigations
! rowspan="3" style="background: #4479BA; color: #FFFFFF; " |Investigations
|-
|-
! colspan="4" |Symptoms
! colspan="4" style="background: #4479BA; color: #FFFFFF; " |Symptoms
! rowspan="2" |Signs
! rowspan="2" style="background: #4479BA; color: #FFFFFF; " |Signs
|-
|-
! style="background: #4479BA; color: #FFFFFF; "|Palpitations
! style="background: #4479BA; color: #FFFFFF; " |Palpitations
! style="background: #4479BA; color: #FFFFFF; "|Fever
! style="background: #4479BA; color: #FFFFFF; " |Fever
! style="background: #4479BA; color: #FFFFFF; "|Sweating
! style="background: #4479BA; color: #FFFFFF; " |Sweating
! style="background: #4479BA; color: #FFFFFF; "|Headache
! style="background: #4479BA; color: #FFFFFF; " |Headache
|-
![[Hypoglycemia]]
| +
| -
| +
| +
|
* [[Tachycardia]]
* Blurred vision
* [[Pallor]]
* [[Tremor|Tremors]]
* [[Seizures]]/ [[Coma]]
|
* Plasma [[glucose]] <70 mg/dL
* Serum [[Insulin]] level
* Serum [[Proinsulin]]
* Serum [[C-peptide|C-Peptide]]
|-
|-
![[Anxiety disorders]]
![[Anxiety disorders]]
Line 179: Line 196:
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|
|
* Patient looks irritable
* Patient looks [[irritable]]


* Rapid [[pulse]] and may be irregular
* Rapid [[pulse]] and may be irregular
|
|
* Normal investigations
* Psychiatry evaluation
|-
|-
![[Pheochromocytoma]]<ref name="pmid11903030">{{cite journal| author=Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P et al.| title=Biochemical diagnosis of pheochromocytoma: which test is best? | journal=JAMA | year= 2002 | volume= 287 | issue= 11 | pages= 1427-34 | pmid=11903030 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11903030  }}</ref><ref name="pmid1787652">{{cite journal| author=Bravo EL| title=Pheochromocytoma: new concepts and future trends. | journal=Kidney Int | year= 1991 | volume= 40 | issue= 3 | pages= 544-56 | pmid=1787652 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1787652  }}</ref>
![[Pheochromocytoma]]<ref name="pmid11903030">{{cite journal| author=Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P et al.| title=Biochemical diagnosis of pheochromocytoma: which test is best? | journal=JAMA | year= 2002 | volume= 287 | issue= 11 | pages= 1427-34 | pmid=11903030 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11903030  }}</ref><ref name="pmid1787652">{{cite journal| author=Bravo EL| title=Pheochromocytoma: new concepts and future trends. | journal=Kidney Int | year= 1991 | volume= 40 | issue= 3 | pages= 544-56 | pmid=1787652 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1787652  }}</ref>
Line 287: Line 304:
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="2" |<small>Diseases</small>
! rowspan="2" |<small>Diseases</small>
! colspan="4" |<small>Diagnostic tests</small>
! colspan="3" |<small>Diagnostic tests</small>
! colspan="5" |<small>Physical Examination</small>
! colspan="5" |<small>Physical Examination</small>
! colspan="3" |<small>Symptoms
! colspan="3" |<small>Symptoms
Line 293: Line 310:
! rowspan="2" |<small>Other Findings</small>
! rowspan="2" |<small>Other Findings</small>
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
!<small>Na+, K+, Ca2+</small>
!<small>CT /MRI</small>
!<small>CT /MRI</small>
!<small>CSF Findings</small>
!<small>CSF Findings</small>
Line 305: Line 321:
!<small>Fever</small>
!<small>Fever</small>
!<small>Altered mental status</small>
!<small>Altered mental status</small>
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hypoglycemia]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Serum blood [[Glucose-1-phosphate adenylyltransferase|glucose]]
[[HbA1c]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;text-align:center" |
| style="background: #F5F5F5; padding: 5px;text-align:center" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |  ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |History of [[Diabetes mellitus|diabetes]]
| style="background: #F5F5F5; padding: 5px;" |[[Palpitation|Palpitations]], [[sweating]], [[dizziness]], low serum, [[glucose]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Brain tumour|Brain tumor]]<ref name="pmid1278192">Soffer D (1976) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=1278192 Brain tumors simulating purulent meningitis.] ''Eur Neurol'' 14 (3):192-7. PMID: [http://pubmed.gov/1278192 1278192]</ref><ref name="pmid3883130" />
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Brain tumour|Brain tumor]]<ref name="pmid1278192">Soffer D (1976) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=1278192 Brain tumors simulating purulent meningitis.] ''Eur Neurol'' 14 (3):192-7. PMID: [http://pubmed.gov/1278192 1278192]</ref><ref name="pmid3883130" />
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px text-align:center" |[[Cancer]] cells<ref name="pmid21371327">{{cite journal| author=Weston CL, Glantz MJ, Connor JR| title=Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. | journal=Fluids Barriers CNS | year= 2011 | volume= 8 | issue= 1 | pages= 14 | pmid=21371327 | doi=10.1186/2045-8118-8-14 | pmc=3059292 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21371327  }}</ref>
| style="background: #F5F5F5; padding: 5px text-align:center" |[[Cancer]] cells<ref name="pmid21371327">{{cite journal| author=Weston CL, Glantz MJ, Connor JR| title=Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. | journal=Fluids Barriers CNS | year= 2011 | volume= 8 | issue= 1 | pages= 14 | pmid=21371327 | doi=10.1186/2045-8118-8-14 | pmc=3059292 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21371327  }}</ref>
Line 323: Line 354:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Delirium tremens]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Delirium tremens]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 339: Line 369:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Subarachnoid hemorrhage|Subarachnoid  hemorrhage]]<ref name="pmid14585453">Yeh ST, Lee WJ, Lin HJ, Chen CY, Te AL, Lin HJ (2003) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=14585453 Nonaneurysmal subarachnoid hemorrhage secondary to tuberculous meningitis: report of two cases.] ''J Emerg Med'' 25 (3):265-70. PMID: [http://pubmed.gov/14585453 14585453]</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Subarachnoid hemorrhage|Subarachnoid  hemorrhage]]<ref name="pmid14585453">Yeh ST, Lee WJ, Lin HJ, Chen CY, Te AL, Lin HJ (2003) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=14585453 Nonaneurysmal subarachnoid hemorrhage secondary to tuberculous meningitis: report of two cases.] ''J Emerg Med'' 25 (3):265-70. PMID: [http://pubmed.gov/14585453 14585453]</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px;" |[[Xanthochromic|Xanthochromia]]<ref name="pmid1198628">{{cite journal| author=Lee MC, Heaney LM, Jacobson RL, Klassen AC| title=Cerebrospinal fluid in cerebral hemorrhage and infarction. | journal=Stroke | year= 1975 | volume= 6 | issue= 6 | pages= 638-41 | pmid=1198628 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1198628  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |[[Xanthochromic|Xanthochromia]]<ref name="pmid1198628">{{cite journal| author=Lee MC, Heaney LM, Jacobson RL, Klassen AC| title=Cerebrospinal fluid in cerebral hemorrhage and infarction. | journal=Stroke | year= 1975 | volume= 6 | issue= 6 | pages= 638-41 | pmid=1198628 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1198628  }}</ref>
Line 356: Line 384:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Stroke]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Stroke]]
| style="background: #F5F5F5; padding: 5px; text-align:center" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | Normal
| style="background: #F5F5F5; padding: 5px; text-align:center" | Normal
Line 372: Line 399:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Neurosyphilis]]<ref name="pmid22482824">{{cite journal| author=Liu LL, Zheng WH, Tong ML, Liu GL, Zhang HL, Fu ZG et al.| title=Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients. | journal=J Neurol Sci | year= 2012 | volume= 317 | issue= 1-2 | pages= 35-9 | pmid=22482824 | doi=10.1016/j.jns.2012.03.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22482824  }} </ref><ref name="pmid24365430">{{cite journal |vauthors=Berger JR, Dean D |title=Neurosyphilis |journal=Handb Clin Neurol |volume=121 |issue= |pages=1461–72 |year=2014 |pmid=24365430 |doi=10.1016/B978-0-7020-4088-7.00098-5 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Neurosyphilis]]<ref name="pmid22482824">{{cite journal| author=Liu LL, Zheng WH, Tong ML, Liu GL, Zhang HL, Fu ZG et al.| title=Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients. | journal=J Neurol Sci | year= 2012 | volume= 317 | issue= 1-2 | pages= 35-9 | pmid=22482824 | doi=10.1016/j.jns.2012.03.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22482824  }} </ref><ref name="pmid24365430">{{cite journal |vauthors=Berger JR, Dean D |title=Neurosyphilis |journal=Handb Clin Neurol |volume=121 |issue= |pages=1461–72 |year=2014 |pmid=24365430 |doi=10.1016/B978-0-7020-4088-7.00098-5 |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px;" |'''↑''' [[Leukocytes]] and [[protein]]
| style="background: #F5F5F5; padding: 5px;" |'''↑''' [[Leukocytes]] and [[protein]]
Line 391: Line 417:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Viral encephalitis]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Viral encephalitis]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |Increased [[RBC]]S or xanthochromia, [[Mononuclear cells|mononuclear]] [[lymphocytosis]], high protein content, normal [[glucose]]
| style="background: #F5F5F5; padding: 5px;" |Increased [[RBC]]S or xanthochromia, [[Mononuclear cells|mononuclear]] [[lymphocytosis]], high protein content, normal [[glucose]]
Line 407: Line 432:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Herpes simplex encephalitis]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Herpes simplex encephalitis]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 423: Line 447:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Wernicke's encephalopathy|Wernicke’s encephalopathy]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Wernicke's encephalopathy|Wernicke’s encephalopathy]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |Normal
Line 439: Line 462:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[CNS abscess]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[CNS abscess]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |'''↑''' [[leukocytes]] >100,000/ul, '''↓''' [[glucose]], '''↑'''[[protein]], '''↑''' red blood cells, and [[lactic acid]] >500mg  
| style="background: #F5F5F5; padding: 5px;" |'''↑''' [[leukocytes]] >100,000/ul, '''↓''' [[glucose]], '''↑'''[[protein]], '''↑''' red blood cells, and [[lactic acid]] >500mg  
Line 456: Line 478:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Drug toxicity]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Drug toxicity]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 472: Line 493:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Conversion disorder]]  
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Conversion disorder]]  
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 488: Line 508:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Electrolyte disturbance]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Electrolyte disturbance]]
| style="background: #F5F5F5; padding: 5px; text-align:center" |'''↓''' or '''↑'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 504: Line 523:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Febrile convulsion]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Febrile convulsion]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |Not performed in first simple febrile [[seizures]]
| style="background: #F5F5F5; padding: 5px; text-align:center" |Not performed in first simple febrile [[seizures]]
Line 520: Line 538:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Subdural empyema]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Subdural empyema]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |
Line 534: Line 551:
| style="background: #F5F5F5; padding: 5px;" |History of relapses and remissions
| style="background: #F5F5F5; padding: 5px;" |History of relapses and remissions
| style="background: #F5F5F5; padding: 5px;" |Blurry vision, [[urinary incontinence]], [[fatigue]]
| style="background: #F5F5F5; padding: 5px;" |Blurry vision, [[urinary incontinence]], [[fatigue]]
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hypoglycemia]]
| style="background: #F5F5F5; padding: 5px; text-align:center" |↓ or '''↑'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Serum blood [[Glucose-1-phosphate adenylyltransferase|glucose]]
[[HbA1c]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;text-align:center" |
| style="background: #F5F5F5; padding: 5px;text-align:center" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |  ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |History of [[Diabetes mellitus|diabetes]]
| style="background: #F5F5F5; padding: 5px;" |[[Palpitation|Palpitations]], [[sweating]], [[dizziness]], low serum, [[glucose]]
|}
|}


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Latest revision as of 22:39, 25 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]

Overview

Hypoglycemia should be differentiated from other causes of autonomic hyperactivity symptoms. Neonatal hypoglycemia should be differentiated from other causes of neurological symptoms in neonates such as sepsis, metabolic diseases: urea cycle disorders, and branched-chain organic acidemias, hyponatremia and neonatal asphyxia. In adults, hypoglycemia should be differentiated from other diseases that may cause autonomic hyperactivity symptoms, such as hyperthyroidism, anxiety, arrhythmia, and pheochromocytoma.

Differentiating Hypoglycemia from other Diseases

Differentiating Different Causes of Hypoglycemia from each other:

Fasting symptoms Postprandial symptoms Plasma insulin C-peptide proinsulin Sulfonylurea in plasma insulin or insulin receptor antibodies
Insulinoma + - high high high - -
Oral hypoglycemia agent-induced - - high high high + -
Autoimmune hypoglycemia - - high high high - +
NIPHS* - + high high high - -
Exogenous insulin - - high low low - -
Non-islet cell tumors - - low low low - -

*(NIPHS) non-insulinoma pancreatogenous hypoglycemia syndrome

Diagnoses Laboratory Findings differentiating among causes of Hypoglycemia
S.Glucose
(mg/dL)
C Peptide (pmol/L) S.Insulin (μU/mL) S.Proinsulin
(pmol/L)
S. Beta hydroxybutyrate Glucose increase after glucagon(mg/dL) Oral Hypoglycemic agent Antibodies to Insulin
Normal/Fasting <55 <200 <3 <5 >2.7 <25 - -
Exogenous Insulin <55 <200 >>3 <5 ≤2.7 >25 - -
Insulinoma <55 ≥200 ≥3 ≥5 ≤2.7 >25 - -
Nesidioblastosis
Post gastric bypass hypoglycemia (PGPH)
Insulin autoimmune hypoglycemia <55 >>200 >>3 >>5 ≤2.7 >25 - +
Oral hypoglycemic agent <55 ≥200 S. ≥5 ≤2.7 >25 + -
IGF¤ <55 <200 <3 <5 ≤2.7 >25 - -

‡ Free C-peptide and proinsulin concentrations are low
¤ IGF= Insulin Growth Factor, Increased pro-IGF-2, free IGF-2, IGF-2/IGF-1 ratio

Differentiating Hypoglycemia from other diseases that cause autonomic hyperactivity symptoms:

Disease Clinical Manifestation Investigations
Symptoms Signs
Palpitations Fever Sweating Headache
Hypoglycemia + - + +
Anxiety disorders + - + +
  • Rapid pulse and may be irregular
  • Psychiatry evaluation
Pheochromocytoma[2][3] + + + +
Arrhythmia + - - -
  • Irregular pulse
  • ECG changes according to the cause
Hyperthyroidism + + + +

Differentiating Hypoglycemia from other Diseases that Cause Neurological Symptoms in Neonates:

Disease History and symptoms Investigations
Family History Lethargy and irritability Improvement of symptoms with glucose intake Fever Hepatomegaly
Hypoglycemia + + + - -
  • Blood glucose level
Sepsis - + - + -
  • Blood cultures
Inborn errors of metabolism + + - - +
  • Positive blood tests
Hyponatremia - + - - -
  • Plasma sodium falls below 125 mEq/L
Perinatal asphyxia + + - - -
  • MRI of acute brain injury confirms the diagnosis of encephalopathy

Differentiating Hypoglycemia from other Diseases that Cause Coma and Consciousness Alterations:

Diseases Diagnostic tests Physical Examination Symptoms Past medical history Other Findings
CT /MRI CSF Findings Gold standard test Neck stiffness Motor or Sensory deficit Papilledema Bulging fontanelle Cranial nerves Headache Fever Altered mental status
Hypoglycemia Serum blood glucose

HbA1c

History of diabetes Palpitations, sweating, dizziness, low serum, glucose
Brain tumor[4][5] Cancer cells[6] MRI Cachexia, gradual progression of symptoms
Delirium tremens Clinical diagnosis Alcohol intake, sudden withdrawal or reduction in consumption Tachycardia, diaphoresis, hypertension, tremors, mydriasis, positional nystagmus,
Subarachnoid hemorrhage[7] Xanthochromia[8] CT scan without contrast[9][10] Trauma/fall Confusion, dizziness, nausea, vomiting
Stroke Normal CT scan without contrast TIAs, hypertension, diabetes mellitus Speech difficulty, gait abnormality
Neurosyphilis[11][12] Leukocytes and protein CSF VDRL-specific

CSF FTA-Ab -sensitive[13]

Unprotected sexual intercourse, STIs Blindness, confusion, depression,

Abnormal gait

Viral encephalitis Increased RBCS or xanthochromia, mononuclear lymphocytosis, high protein content, normal glucose Clinical assesment Tick bite/mosquito bite/ viral prodrome for several days Extreme lethargy, rash hepatosplenomegaly, lymphadenopathy, behavioral changes
Herpes simplex encephalitis Clinical assesment History of hypertension Delirium, cortical blindness, cerebral edema, seizure
Wernicke’s encephalopathy Normal History of alcohol abuse Ophthalmoplegia, confusion
CNS abscess leukocytes >100,000/ul, glucose, protein, red blood cells, and lactic acid >500mg Contrast enhanced MRI is more sensitive and specific,

Histopathological examination of brain tissue

History of drug abuse, endocarditis, immune status High-grade fever, fatigue, nausea, vomiting
Drug toxicity Lithium, Sedatives, phenytoin, carbamazepine
Conversion disorder Diagnosis of exclusion Tremors, blindness, difficulty swallowing
Electrolyte disturbance Depends on the cause Confusion, seizures
Febrile convulsion Not performed in first simple febrile seizures Clinical diagnosis and EEG Family history of febrile seizures, viral illness or gastroenteritis Age > 1 month,
Subdural empyema Clinical assessment and MRI History of relapses and remissions Blurry vision, urinary incontinence, fatigue

References

  1. Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER; et al. (2009). "Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline". J Clin Endocrinol Metab. 94 (3): 709–28. doi:10.1210/jc.2008-1410. PMID 19088155.
  2. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P; et al. (2002). "Biochemical diagnosis of pheochromocytoma: which test is best?". JAMA. 287 (11): 1427–34. PMID 11903030.
  3. Bravo EL (1991). "Pheochromocytoma: new concepts and future trends". Kidney Int. 40 (3): 544–56. PMID 1787652.
  4. Soffer D (1976) Brain tumors simulating purulent meningitis. Eur Neurol 14 (3):192-7. PMID: 1278192
  5. Weston CL, Glantz MJ, Connor JR (2011). "Detection of cancer cells in the cerebrospinal fluid: current methods and future directions". Fluids Barriers CNS. 8 (1): 14. doi:10.1186/2045-8118-8-14. PMC 3059292. PMID 21371327.
  6. Yeh ST, Lee WJ, Lin HJ, Chen CY, Te AL, Lin HJ (2003) Nonaneurysmal subarachnoid hemorrhage secondary to tuberculous meningitis: report of two cases. J Emerg Med 25 (3):265-70. PMID: 14585453
  7. Lee MC, Heaney LM, Jacobson RL, Klassen AC (1975). "Cerebrospinal fluid in cerebral hemorrhage and infarction". Stroke. 6 (6): 638–41. PMID 1198628.
  8. Birenbaum D, Bancroft LW, Felsberg GJ (2011). "Imaging in acute stroke". West J Emerg Med. 12 (1): 67–76. PMC 3088377. PMID 21694755.
  9. DeLaPaz RL, Wippold FJ, Cornelius RS, Amin-Hanjani S, Angtuaco EJ, Broderick DF; et al. (2011). "ACR Appropriateness Criteria® on cerebrovascular disease". J Am Coll Radiol. 8 (8): 532–8. doi:10.1016/j.jacr.2011.05.010. PMID 21807345.
  10. Liu LL, Zheng WH, Tong ML, Liu GL, Zhang HL, Fu ZG; et al. (2012). "Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients". J Neurol Sci. 317 (1–2): 35–9. doi:10.1016/j.jns.2012.03.003. PMID 22482824.
  11. Berger JR, Dean D (2014). "Neurosyphilis". Handb Clin Neurol. 121: 1461–72. doi:10.1016/B978-0-7020-4088-7.00098-5. PMID 24365430.
  12. Ho EL, Marra CM (2012). "Treponemal tests for neurosyphilis--less accurate than what we thought?". Sex Transm Dis. 39 (4): 298–9. doi:10.1097/OLQ.0b013e31824ee574. PMC 3746559. PMID 22421697.